General MedicationsINJECTIONGeneric
TERRAMYCIN
OXYTETRACYCLINE HYDROCHLORIDE
Standard Dose
EQ 250MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview TERRAMYCIN is listed in Drugs@FDA under application 060586 (ANDA).
Marketing status: Discontinued Active ingredient OXYTETRACYCLINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 250MG BASE/VIAL Sponsor PFIZER Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview TERRAMYCIN is listed in Drugs@FDA under application 060586 (ANDA). Marketing status: Discontinued Active ingredient OXYTETRACYCLINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 250MG BASE/VIAL Sponsor PFIZER Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.